4-aminopyridine has been researched along with Atrophy in 1 studies
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalla, R | 1 |
| Glasauer, S | 1 |
| Büttner, U | 1 |
| Brandt, T | 1 |
| Strupp, M | 1 |
1 trial available for 4-aminopyridine and Atrophy
| Article | Year |
|---|---|
4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus.
Topics: 4-Aminopyridine; Adult; Aged; Atrophy; Cerebellum; Eye Movements; Female; Fixation, Ocular; Humans; | 2007 |